BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1600 related articles for article (PubMed ID: 29023288)

  • 1. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
    Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
    Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut microbiota in cardiovascular diseases.
    Novakovic M; Rout A; Kingsley T; Kirchoff R; Singh A; Verma V; Kant R; Chaudhary R
    World J Cardiol; 2020 Apr; 12(4):110-122. PubMed ID: 32431782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota in Cardiovascular Health and Disease.
    Tang WH; Kitai T; Hazen SL
    Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
    Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and cardiovascular diseases axis.
    Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
    Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.
    Tang WHW; Bäckhed F; Landmesser U; Hazen SL
    J Am Coll Cardiol; 2019 Apr; 73(16):2089-2105. PubMed ID: 31023434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota derived metabolites in cardiovascular health and disease.
    Wang Z; Zhao Y
    Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.